Mississauga, Canada
Membio Inc., founded in 2018, is at the forefront of revolutionizing the biotechnology and pharmaceutical industries. Headquartered in Canada, the company has the bold slogan: "Scalable single-use bioreactors," encapsulating its mission to transform the way cells are grown for medical purposes.
The challenge Membio addresses is the prohibitively high manufacturing costs of cell and gene therapies, which limits their accessibility. By developing a single-use benchtop bioreactor system, Membio offers a solution for the cost-effective and scalable production of therapeutic cells, potentially widening patient access to advanced treatments.
The company attracted a $3.22M Seed Round investment on 20 April 2020, backed by notable investors such as SOSV, VU Venture Partners, True Ventures, indiebio, Boom Capital Ventures, and Ramen Ventures. This financial injection marks investor confidence in Membio's potential to innovate within the healthcare sector and disrupt existing manufacturing paradigms.
